
Genesis IBRC Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-12-04 11:08:06Genesis IBRC, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of volatile stock returns and a complex fundamental profile.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Lower Circuit Lockdown
2025-12-04 09:35:10Genesis IBRC India Ltd has encountered severe selling pressure on 4 Dec 2025, with the stock hitting the lower circuit and registering exclusively sell orders. This distress selling signals a critical phase for the pharmaceutical and biotechnology company as it experiences consecutive losses and a sharp decline in market sentiment.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Prolonged Downtrend
2025-12-03 09:40:10Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting a persistent downtrend over the past sixteen trading sessions. The absence of buyers and continuous sell orders have resulted in a distressing market scenario for this Pharmaceuticals & Biotechnology company.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-02 09:35:11Genesis IBRC India Ltd is currently experiencing severe selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This situation signals distress selling and highlights a challenging phase for the pharmaceutical and biotechnology company amid a series of consecutive losses over recent weeks.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-01 09:30:11Genesis IBRC India has encountered significant selling pressure, with the stock registering a day marked exclusively by sell orders. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum following a prolonged period of consecutive losses.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-28 10:40:08Genesis IBRC India is currently experiencing significant selling pressure, with the stock locked at its lower circuit and an absence of buyers in the market. This distress selling has resulted in a continuous decline over the past 13 trading sessions, signalling a challenging phase for the pharmaceutical and biotechnology company.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-27 10:40:11Genesis IBRC India Ltd is currently experiencing significant selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This distress selling has resulted in a continuous decline over the past 12 trading sessions, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-26 11:25:06Genesis IBRC India Ltd is currently experiencing a pronounced selling wave, with the stock locked at its lower circuit and an absence of buyers in the queue. This extreme selling pressure has resulted in an uninterrupted decline over the past 11 trading sessions, signalling distress among investors in the Pharmaceuticals & Biotechnology sector.
Read More
Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-25 12:20:07Genesis IBRC India has encountered significant selling pressure in the latest trading session, with the stock registering a decline of 2.00% while the Sensex showed a marginal gain of 0.06%. The absence of buyers and a queue dominated solely by sell orders signal distress selling, marking a notable shift in market sentiment for the pharmaceutical and biotechnology company.
Read MoreShareholder Meeting / Postal Ballot-Notice of Postal Ballot
02-Feb-2026 | Source : BSENotice of Postal Ballot for Genesis IBRC India Limited.
Board Meeting Outcome for Outcome Of Board Meeting Held On 28-01-2026
28-Jan-2026 | Source : BSEThe Board of Directors of Genesis IBRC India Limited (Company) in their meeting held today i.e. Wednesday January 28 2026 have inter alia considered recommended and approved the matters as specified in the outcome of board meeting.
Announcement under Regulation 30 (LODR)-Issue of Securities
28-Jan-2026 | Source : BSEIntimation under Regulation 30 of matters considered and approved at the board meeting held on 28-01-2026. The details are in attached file.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available